TFA Therapeutics (RAJAF) Cost of Revenue (2020 - 2023)
TFA Therapeutics (RAJAF) posted Cost of Revenue of $30842.0 for Q4 2023, down 24.12% on a QoQ basis from $40648.0 in Q4 2020.
Powered by 
Analysis
TFA Therapeutics (RAJAF) Cost of Revenue (2020 - 2023) Analysis & Trends
TFA Therapeutics has reported Cost of Revenue for 2 years, with the latest figure at $30842.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 69.71 Bn | 68.67 Bn | 3.30 Bn | 2.07 Bn |
| 2 | Kenvue | 34.22 Bn | 33.11 Bn | 2.30 Bn | 1.65 Bn |
| 3 | Kimberly Clark | 32.55 Bn | 31.72 Bn | 1.60 Bn | 2.59 Bn |
| 4 | Bath & Body Works | 3.52 Bn | 2.73 Bn | 692.00 Mn | 822.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.52 Bn | 2.46 Bn | - | - |
| 6 | Perrigo | 1.88 Bn | 1.49 Bn | 313.90 Mn | 708.90 Mn |
| 7 | Edgewell Personal Care | 1.25 Bn | 854.93 Mn | 242.50 Mn | 327.60 Mn |
| 8 | Herbalife | 1.25 Bn | 883.17 Mn | 1.03 Bn | 466.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 611.15 Mn | 505.26 Mn | 40.36 Mn | 42.94 Mn |